可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 臧益民,樊荣. 加强多学科协作,争取心血管病研究取得进展[J]. 心脏杂志, 2006, 18(5):483-488.
[2] Chalikias GK, Tziakas DN, Kaski JC, et al.Interleukin18: interleukin10 ratio and inhospital adverse events in patients with acute coronary syndrome[J]. Atherosclerosis, 2005, 182 (1):135-143.
[3] Koenig W, Khuseyinova N, Baumert J, et al. Increased concentrations of Creactive protein and IL6 but not IL18 are independently associated with incident coronary events in middleaged men and women: results from the MONICA/KORA Augsburg casecohort study, 19842002[J]. Arterioscler Thromb Vasc Biol, 2006, 26(12):2745-2751.
[4] Dubey L, Hesong Z. Antiinflammatory action of diltiazem in patients with unstable angina[J]. Postgrad Med J, 2006, 82(971):594-597.
[5] Mazighi M, Pelle A, Gonzalez W, et al. IL10 inhibits vascular smooth muscle cell activation in vitro and in vivo[J]. Am J Physiol Heart Circ Physiol, 2004, 287(2):H866-H871.
[6] Monraats PS, Kurreeman FA, Pons D, et al. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention[J]. Genes Immun, 2007, 8(1):44-50.
[7] Heinisch RH, Zanetti CR, Comin F, et al. Serial changes in plasma levels of cytokines in patients with coronary artery disease[J]. Vasc Health Risk Manag, 2005, 1(3):245-250.
[8]Mysliwska J, Wieckiewicz J, Hak L, et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries[J]. Eur Cytokine Netw, 2006, 17(3):181-188.
[9] Stefan KJ, Paul A, Elliott B, et al. Tropoein and Creactive protein have different relational to subsequent mortality and myocardial infarction after acute coronary syndrome[J]. J Am Coll Cardiol, 2003, 41(5):916-924.
[10]Saleh N, Tornvall P. Serum Creactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis[J]. Atherosclerosis, 2006, 70 (6):538-540.
[11]Kozinski M, Kubica J, Sukiennik A, et al. Periprocedural soluble P and Eselectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting[J]. Circulation, 2007, 19(1):187-195.
[12]Sattar N, Murray HM, McConnachie A, et al. CReactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER)[J]. Circulation, 2007, 115(8):981-989.
[13]Guray U, Erbay AR, Guray Y, et al. Levels of solube adhesion molecules in various clinical presentations of coronary atherosclerosis[J]. Int J Cardiol, 2004, 96(2):235-240.
[14]Kollum M, Hoefer I, Schreiber R, et al. Systemic application of antiICAM1 monoclonal antibodies to prevent restenosis in rabbits: an antiinflammatory strategy[J].Coron Artery Dis, 2007, 18 (2):117-123.
[15]Merten M, Thiagarajan P. Pselectin in arterial thrombosis[J]. Z Kardiol, 2004, 93(11):855-863.
[16]Venturinelli ML, Hovnan A, Soeiro Ade M, et al. Platelet activation in different clinical forms of the coronary artery disease (roll of Pselectin and others platelet markers in the stable and unstable angina)[J]. Arq Bras Cardiol, 2006, 87(4):446-450.
[17]Inami N, Nomura S, Manabe K, et al. Plateletderived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris[J]. Platelets, 2006, 17(8):565-570.
[18]林国强,蒋海河,李迎秋. CHD患者血浆血管性血友病因子、可溶性E选择素的变化及意义[J]. 中南大学学报, 2005, 30(4):399-402.
[19]AbuAmero KK, AlBoudari OM, Mohamed GH, et al. Eselectin S128R polymorphism and severe coronary artery disease in Arabs[J]. BMC Med Genet, 2006, 7:52.
[20]Miller MA, Kerry SM, Dong Y, et al. Circulating soluble Eselectin levels and the Ser 128Arg polymorphism in individuals from different ethnic groups[J]. Nutr Metab Cardiovasc Dis, 2005, 15 (1):65-70.
[21]Kilickap M, Tutar E, Aydintug O, et al. Increase in soluble Eselectin level after PTCA and stent implantation: a potential marker of restenosis[J]. Int J Cardiol, 2004, 93(1):13-18.
[22]Seino Y, Ogawa A, Yamashita T, et al. Multibiomarker approach to acute coronary syndrome[J]. Nippon Rinsho, 2006, 64(4):691-699.